Degu Dare

Senior Epidemiologist

Degu Dare is a medical doctor with 24 years professional experience working in TB and HIV disease control programmes and epidemiology.

Degu has contributed to over 60 academic articles and is an expert in TB epidemiology, infectious disease management (including TB and HIV/AIDS), capacity building, ministry of health processes, community-based TB services, integrated diabetes/TB/HIV service delivery, TB surveillance and contact screening and health systems strengthening. Degu has previously worked at the World Health Organization, Johns Hopkins University, and Management Sciences for Health.

As the project director of the USAID-funded Challenge TB Project in Ethiopia, Degu developed innovative TB contact screening approaches, led a nation-wide survey on population-based TB awareness and stigma, coordinated the introduction of an integrated specimen transport system both for sputum and viral load testing and introduced innovative digital technologies (99DOTS, online screening, video-conferencing, DHIS-2) to support capacity building, case finding and adherence support.

In addition to his Doctorate in International Public Health from the University of Bergen, Norway in 2007, Degu holds a Master of Business Administration from Ashland University, USA. Degu currently serves as Associate Editor for two peer-reviewed journals: Public Health Action and Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, and is the current Vice Chair of the Union’s HIV Section. Degu was also part of the WHO-convened global team that developed global TB data compendium for the patient pathway analysis compendium.

Within KNCV, Degu supports the development and revision of national strategic plans for TB, epidemiological reviews and assessments, and the design and implementation of innovative health projects, including community-based TPT, childhood TB diagnosis, and digital health interventions. Degu also works on the implementation of the KNCV-led patient-centered framework for strategic planning in Africa and led the research and epidemiology team contributing to design of KNCV’s innovation pathways and KNCV’s research ethics review. Degu represents KNCV on the Global Fund’s TB measurement taskforce.

Recent publications

Mengesha MM, Gebremichael MA, Watumo D, Hallström IK, Jerene D (2022) Poor adult tuberculosis treatment outcome and associated factors in Gibe Woreda, Southern Ethiopia: An institution-based cross-sectional study. PLOS Glob Public Health 2(3) 2022. Abstract


Mengesha MM, Gebremichael MA, Watumo D, Hallström IK, Jerene D. Poor adult tuberculosis treatment outcome and associated factors in Gibe Woreda, Southern Ethiopia: An institution-based cross-sectional study. PLOS Glob Public Health 2022;2(3). Abstract


Degu Jerene, Dawid Assefa, Kalkidan Tesfaye, Samuel Bayu, Samuel Seid, Fikirte Aberra, Ahmed Bedru, et al. Effectiveness of women-led community interventions in improving tuberculosis preventive treatment in children: results from a comparative, before–after study in Ethiopia. BMJ Open 2022;12:e062298. doi:10.1136/ bmjopen-2022-062298. Full paper.

 

read all the KNCV publications

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us

Tuberculosis is still one of the major causes of preventable death in the world and claims over 4000 lives a day, leading to over 1,5 million deaths a year.

Patient stories

The story of Abdurahim
The story of Fikeraddis
The story of Issayas
The story of Zarina
The story of Maxine
The story of Saanvi

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.